Sequential peritoneal equilibration test (sPET) is based on the consecutive performance of the peritoneal equilibration test (PET, 4-hour, glucose 2.27%) and the mini-PET (1-hour, glucose 3.86%), and the estimation of peritoneal transport parameters with the 2-pore model. It enables the assessment of the functional transport barrier for fluid and small solutes. The objective of this study was to check whether the estimated model parameters can serve as better and earlier indicators of the changes in the peritoneal transport characteristics than directly measured transport indices that depend on several transport processes.
17 patients were examined using sPET twice with the interval of about 8 months (230 ± 60 days).
There was no difference between the observational parameters measured in the 2 examinations. The indices for solute transport, but not net UF, were well correlated between the examinations. Among the estimated parameters, a significant decrease between the 2 examinations was found only for hydraulic permeability LpS, and osmotic conductance for glucose, whereas the other parameters remained unchanged. These fluid transport parameters did not correlate with D/P for creatinine, although the decrease in LpS values between the examinations was observed mostly for patients with low D/P for creatinine.
We conclude that changes in fluid transport parameters, hydraulic permeability and osmotic conductance for glucose, as assessed by the pore model, may precede the changes in small solute transport. The systematic assessment of fluid transport status needs specific clinical and mathematical tools beside the standard PET tests.
Int J Artif Organs 2017; 40(11): 595 - 601
Article Type: ORIGINAL RESEARCH ARTICLE
AuthorsJacek Waniewski, Stefan Antosiewicz, Daniel Baczynski, Jan Poleszczuk, Mauro Pietribiasi, Bengt Lindholm, Zofia Wankowicz
- • Accepted on 14/06/2017
- • Available online on 11/07/2017
- • Published in print on 27/10/2017
This article is available as full text PDF.
- Waniewski, Jacek [PubMed] [Google Scholar] 1, * Corresponding Author (firstname.lastname@example.org)
- Antosiewicz, Stefan [PubMed] [Google Scholar] 2
- Baczynski, Daniel [PubMed] [Google Scholar] 2
- Poleszczuk, Jan [PubMed] [Google Scholar] 1
- Pietribiasi, Mauro [PubMed] [Google Scholar] 1
- Lindholm, Bengt [PubMed] [Google Scholar] 3
- Wankowicz, Zofia [PubMed] [Google Scholar] 2
Nalecz Institute of Biocybernetics and Biomedical Engineering, Polish Academy of Sciences, Warsaw - Poland
Military Institute of Medicine, Warsaw - Poland
Division of Renal Medicine and Baxter Novum, Department of Clinical Science, Intervention and Technology, Karolinska Institute, Stockholm - Sweden